Candesartan Cilexetil, a Novel Angiotensin II Antagonist, Provides Dose-dependent Antihypertensive Effect with Maintained Tolerability

Author： ELMFELDT D. GEORGE M. HÜBNER R. OLOFSSON B.

Publisher： Informa Healthcare

ISSN： 0803-7051

Source： Blood Pressure, Vol.9, Iss.1, 2000-05, pp. : 54-54

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Antihypertensive Effect and Tolerability of Candesartan Cilexetil, a New Generation Angiotensin II Antagonist, in Comparison with Losartan

By ANDERSSON OVE K. NELDAM STEEN

Blood Pressure, Vol. 7, Iss. 1, 1998-04 ,pp. : 53-59

Informa Healthcare

Access to resources Recommend Favorite

Antihypertensive Effects and Tolerability of Candesartan Cilexetil in an Elderly Population

By MCINNES G. T. JONKER J.

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 58-58

Informa Healthcare

Access to resources Recommend Favorite

Candesartan Cilexetil, 16 mg, Provides a Greater Antihypertensive Effect than Losartan, 50 mg, in Patients with Mild to Moderate Hypertension

By ANDERSSON O. K. NELDAM S.

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 55-55

Informa Healthcare

Access to resources Recommend Favorite

Candesartan Cilexetil, a Novel Angiotensin II Type 1 (AT1) Receptor Blocker, Reduces Microalbuminuria in Patients with Type II Diabetes Mellitus and Mild Hypertension

By TRENKWALDER P. DAHL K. LEHTOVIRTA M. MULDER H.

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 57-57

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Tolerability of Candesartan Cilexetil in Special Patient Groups

By TRENKWALDER PETER

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 27-30

Informa Healthcare

Access to resources Recommend Favorite